| Horizon Counseling, Llc | |
|
145 Pine Haven Shores Rd Ste 1000-50 Shelburne VT 05482-7703 | |
| (802) 333-0245 | |
| Not Available |
| Full Name | Horizon Counseling, Llc |
|---|---|
| Speciality | Social Worker |
| Location | 145 Pine Haven Shores Rd Ste 1000-50, Shelburne, Vermont |
| Authorized Official Name and Position | Zachary Galkin (BUSINESS OWNER) |
| Authorized Official Contact | 8023330245 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Horizon Counseling, Llc 145 Pine Haven Shores Rd Ste 1000-50 Shelburne VT 05482-7703 Ph: (802) 333-0245 | Horizon Counseling, Llc 145 Pine Haven Shores Rd Ste 1000-50 Shelburne VT 05482-7703 Ph: (802) 333-0245 |
| NPI Number | 1376127100 |
|---|---|
| Provider Enumeration Date | 05/07/2021 |
| Last Update Date | 01/12/2024 |
| Certification Date | 01/12/2024 |
| Medicare PECOS PAC ID | 1850791047 |
|---|---|
| Medicare Enrollment ID | O20210609001975 |
News Archive
A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.
The May issue of the WHO Bulletin features an editorial on the establishment of an evidence base for e-health; a public health round-up;
A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been so difficult. In the report, an Australian scientist explains how he used computer simulations to discover that a population starting from a single human immunodeficiency virus can evolve fast enough to escape immune defenses.
Bristol-Myers Squibb Company and Alder Biopharmaceuticals, Inc., today announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376127100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Zachary Galkin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831631241 PECOS PAC ID: 0547540528 Enrollment ID: I20161208001618 |
News Archive
A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.
The May issue of the WHO Bulletin features an editorial on the establishment of an evidence base for e-health; a public health round-up;
A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been so difficult. In the report, an Australian scientist explains how he used computer simulations to discover that a population starting from a single human immunodeficiency virus can evolve fast enough to escape immune defenses.
Bristol-Myers Squibb Company and Alder Biopharmaceuticals, Inc., today announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
› Verified 1 days ago
News Archive
A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.
The May issue of the WHO Bulletin features an editorial on the establishment of an evidence base for e-health; a public health round-up;
A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been so difficult. In the report, an Australian scientist explains how he used computer simulations to discover that a population starting from a single human immunodeficiency virus can evolve fast enough to escape immune defenses.
Bristol-Myers Squibb Company and Alder Biopharmaceuticals, Inc., today announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
› Verified 1 days ago
Montera Health Vermont Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 145 Pine Haven Shores Rd Ste 1000a, Shelburne, VT 05482 Phone: 865-680-1516 | |
Lisa Hardy, Aprn, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 145 Pine Haven Shores Rd, Shelburne, VT 05482 Phone: 802-349-1408 | |
Carina Antonino Dimare, Ms, Plc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1009 Falls Rd, Shelburne, VT 05482 Phone: 413-374-3921 | |
Solid Ground Psychiatry Plc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 145 Pine Haven Shores Rd Ste 1011, Shelburne, VT 05482 Phone: 802-488-0048 Fax: 802-209-8024 | |
Brian Tobin, Lcmhc, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 291 Bostwick Farm Road, Shelburne, VT 05482 Phone: 802-332-5566 | |
Emily Pichler Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 145 Pine Haven Shores Rd Ste 1000, Shelburne, VT 05482 Phone: 802-448-2243 |